Literature DB >> 30507678

Spinal cord perfusion protection for thoraco-abdominal aortic aneurysm surgery.

Lovkesh Arora1, Maen Aboul Hosn2.   

Abstract

PURPOSE OF REVIEW: Spinal cord ischemia (SCI) is a devastating complication after open or endovascular aortic repair for thoracoabdominal aortic disease. The underlying pathogenesis is not fully understood but appears multifactorial. Multiple spinal cord protection strategies and monitoring techniques are currently utilized with variable results seen. The purpose of this review is to summarize important and recent findings related to cause, monitoring and impact of multiple spinal cord protection strategies. RECENT
FINDINGS: Recent data suggests collateral blood flow as the major determinant of spinal cord perfusion instead of individual intercostal vessels, potential role of transcutaneous near-infrared spectroscopy for monitoring of spinal cord perfusion and positive impact of implementing multimodal spinal cord protection strategies on reducing the risk of SCI.
SUMMARY: SCI leading to paraplegia is a multifactorial complication that remains a major concern in complex aortic surgeries. Although there are no sufficient data to document the efficacy of spinal cord protection techniques individually, their effect on lowering the risk of SCI is most evident when used concomitantly using a multimodal approach that encompasses the perioperative and early postoperative period.

Entities:  

Mesh:

Year:  2019        PMID: 30507678     DOI: 10.1097/ACO.0000000000000670

Source DB:  PubMed          Journal:  Curr Opin Anaesthesiol        ISSN: 0952-7907            Impact factor:   2.706


  2 in total

Review 1.  Interventions to improve perioperative neurologic outcomes.

Authors:  Matthew S Vandiver; Susana Vacas
Journal:  Curr Opin Anaesthesiol       Date:  2020-10       Impact factor: 2.706

2.  Commentary: Cerebrospinal fluid drainage: One component of a successful distal aortic surgery program.

Authors:  Marina Ibrahim; Jennifer C-Y Chung; Thomas F Lindsay; Maral Ouzounian
Journal:  JTCVS Tech       Date:  2021-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.